miRNA deregulation in multiple myeloma

Multiple myeloma （MM） is an incurable plasma cell malignancy and is the second most common hematological cancer. It is characterized by complex, recurrent genetic and epigenetic abnormalities. Recent publications have linked miRNAs, a novel class of gene regulators to cancer including MM. miRNAs are...

Full description

Saved in:
Bibliographic Details
Published in:Chinese medical journal 2011-10, Vol.124 (19), p.3164-3169
Main Authors: Bi, Chong Lei, Chng, Wee Joo
Format: Article
Language:English
Subjects:
Humans
MicroRNAs - physiology
miRNA
Multiple Myeloma - genetics
基因表达
多发性骨髓瘤
恶性肿瘤
放松管制
监管机构
表观遗传
非编码RNA
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 3169
container_issue 19
container_start_page 3164
container_title Chinese medical journal
container_volume 124
creator Bi, Chong Lei
Chng, Wee Joo
description Multiple myeloma （MM） is an incurable plasma cell malignancy and is the second most common hematological cancer. It is characterized by complex, recurrent genetic and epigenetic abnormalities. Recent publications have linked miRNAs, a novel class of gene regulators to cancer including MM. miRNAs are about 20 nucleotide, single strand, non-coding RNAs that repress gene expression by mRNA degradation or translational repression. Aberrant miRNA expression profiles have been described in MM, and their functional roles in MM pathogenesis are being increasingly recognized. This review summarizes the current literature on the role of miRNAs in MM and offers perspectives on future research and utilization of miRNAs in MM management.
doi_str_mv 10.3760/cma.j.issn.0366-6999.2011.19.037
format article
fullrecord <record><control><sourceid>wanfang_jour_proqu</sourceid><recordid>TN_cdi_wanfang_journals_zhcmj201119037</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>39797616</cqvip_id><wanfj_id>zhcmj201119037</wanfj_id><sourcerecordid>zhcmj201119037</sourcerecordid><originalsourceid>FETCH-LOGICAL-c267t-7a1db8e30d37b9e97bf281748855cc3476043fe8042f0c153b9d2f06241b01463</originalsourceid><addsrcrecordid>eNo9kF1LwzAYhYMobk7_gtSb6U1rvtNcjuEXDAXR65Km6ZbSpFuzIvPXm7HNq_fw8nAO5wDwgGBGBIeP2qmsyWwIPoOE85RLKTMMEcqQjB9xBsaYUZwyTtE5GP8zI3AVQgMhZkzwSzDCGFLIBBmDqbOf77OkMr1ZDq3a2s4n1iduaLd23ZrE7UzbOXUNLmrVBnNzvBPw_fz0NX9NFx8vb_PZItWYi20qFKrK3BBYEVFKI0VZ4xwJmueMaU1o7EBJbXJIcQ01YqSUVVQcU1RCRDmZgOnB90f5Wvll0XRD72Ni8bvSrtlXRTIWjeD9AVz33WYwYVs4G7RpW-VNN4RCQhQ34GJveXskh9KZqlj31ql-V5w2iMDdAdCrzi83NqaeGCKFFBxx8geqpWq9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>901641676</pqid></control><display><type>article</type><title>miRNA deregulation in multiple myeloma</title><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><creator>Bi, Chong Lei ; Chng, Wee Joo</creator><creatorcontrib>Bi, Chong Lei ; Chng, Wee Joo</creatorcontrib><description>Multiple myeloma （MM） is an incurable plasma cell malignancy and is the second most common hematological cancer. It is characterized by complex, recurrent genetic and epigenetic abnormalities. Recent publications have linked miRNAs, a novel class of gene regulators to cancer including MM. miRNAs are about 20 nucleotide, single strand, non-coding RNAs that repress gene expression by mRNA degradation or translational repression. Aberrant miRNA expression profiles have been described in MM, and their functional roles in MM pathogenesis are being increasingly recognized. This review summarizes the current literature on the role of miRNAs in MM and offers perspectives on future research and utilization of miRNAs in MM management.</description><identifier>ISSN: 0366-6999</identifier><identifier>EISSN: 2542-5641</identifier><identifier>DOI: 10.3760/cma.j.issn.0366-6999.2011.19.037</identifier><identifier>PMID: 22040573</identifier><language>eng</language><publisher>China: Cancer Science Institute of Singapore, National University of Singapore, Singapore (Bi CL and Chng WJ)%Cancer Science Institute of Singapore, National University of Singapore, Singapore</publisher><subject>Humans ; MicroRNAs - physiology ; miRNA ; Multiple Myeloma - genetics ; 基因表达 ; 多发性骨髓瘤 ; 恶性肿瘤 ; 放松管制 ; 监管机构 ; 表观遗传 ; 非编码RNA</subject><ispartof>Chinese medical journal, 2011-10, Vol.124 (19), p.3164-3169</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85656X/85656X.jpg</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22040573$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bi, Chong Lei</creatorcontrib><creatorcontrib>Chng, Wee Joo</creatorcontrib><title>miRNA deregulation in multiple myeloma</title><title>Chinese medical journal</title><addtitle>Chinese Medical Journal</addtitle><description>Multiple myeloma （MM） is an incurable plasma cell malignancy and is the second most common hematological cancer. It is characterized by complex, recurrent genetic and epigenetic abnormalities. Recent publications have linked miRNAs, a novel class of gene regulators to cancer including MM. miRNAs are about 20 nucleotide, single strand, non-coding RNAs that repress gene expression by mRNA degradation or translational repression. Aberrant miRNA expression profiles have been described in MM, and their functional roles in MM pathogenesis are being increasingly recognized. This review summarizes the current literature on the role of miRNAs in MM and offers perspectives on future research and utilization of miRNAs in MM management.</description><subject>Humans</subject><subject>MicroRNAs - physiology</subject><subject>miRNA</subject><subject>Multiple Myeloma - genetics</subject><subject>基因表达</subject><subject>多发性骨髓瘤</subject><subject>恶性肿瘤</subject><subject>放松管制</subject><subject>监管机构</subject><subject>表观遗传</subject><subject>非编码RNA</subject><issn>0366-6999</issn><issn>2542-5641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNo9kF1LwzAYhYMobk7_gtSb6U1rvtNcjuEXDAXR65Km6ZbSpFuzIvPXm7HNq_fw8nAO5wDwgGBGBIeP2qmsyWwIPoOE85RLKTMMEcqQjB9xBsaYUZwyTtE5GP8zI3AVQgMhZkzwSzDCGFLIBBmDqbOf77OkMr1ZDq3a2s4n1iduaLd23ZrE7UzbOXUNLmrVBnNzvBPw_fz0NX9NFx8vb_PZItWYi20qFKrK3BBYEVFKI0VZ4xwJmueMaU1o7EBJbXJIcQ01YqSUVVQcU1RCRDmZgOnB90f5Wvll0XRD72Ni8bvSrtlXRTIWjeD9AVz33WYwYVs4G7RpW-VNN4RCQhQ34GJveXskh9KZqlj31ql-V5w2iMDdAdCrzi83NqaeGCKFFBxx8geqpWq9</recordid><startdate>201110</startdate><enddate>201110</enddate><creator>Bi, Chong Lei</creator><creator>Chng, Wee Joo</creator><general>Cancer Science Institute of Singapore, National University of Singapore, Singapore (Bi CL and Chng WJ)%Cancer Science Institute of Singapore, National University of Singapore, Singapore</general><general>Department of Haematology-Oncology, National University Cancer Institute of Singapore, National University Health System,Singapore</general><general>Department of Medicine, Yong Loo Lin School of Medicine,National University of Singapore, Singapore</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>201110</creationdate><title>miRNA deregulation in multiple myeloma</title><author>Bi, Chong Lei ; Chng, Wee Joo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c267t-7a1db8e30d37b9e97bf281748855cc3476043fe8042f0c153b9d2f06241b01463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Humans</topic><topic>MicroRNAs - physiology</topic><topic>miRNA</topic><topic>Multiple Myeloma - genetics</topic><topic>基因表达</topic><topic>多发性骨髓瘤</topic><topic>恶性肿瘤</topic><topic>放松管制</topic><topic>监管机构</topic><topic>表观遗传</topic><topic>非编码RNA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bi, Chong Lei</creatorcontrib><creatorcontrib>Chng, Wee Joo</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>Chinese medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bi, Chong Lei</au><au>Chng, Wee Joo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>miRNA deregulation in multiple myeloma</atitle><jtitle>Chinese medical journal</jtitle><addtitle>Chinese Medical Journal</addtitle><date>2011-10</date><risdate>2011</risdate><volume>124</volume><issue>19</issue><spage>3164</spage><epage>3169</epage><pages>3164-3169</pages><issn>0366-6999</issn><eissn>2542-5641</eissn><abstract>Multiple myeloma （MM） is an incurable plasma cell malignancy and is the second most common hematological cancer. It is characterized by complex, recurrent genetic and epigenetic abnormalities. Recent publications have linked miRNAs, a novel class of gene regulators to cancer including MM. miRNAs are about 20 nucleotide, single strand, non-coding RNAs that repress gene expression by mRNA degradation or translational repression. Aberrant miRNA expression profiles have been described in MM, and their functional roles in MM pathogenesis are being increasingly recognized. This review summarizes the current literature on the role of miRNAs in MM and offers perspectives on future research and utilization of miRNAs in MM management.</abstract><cop>China</cop><pub>Cancer Science Institute of Singapore, National University of Singapore, Singapore (Bi CL and Chng WJ)%Cancer Science Institute of Singapore, National University of Singapore, Singapore</pub><pmid>22040573</pmid><doi>10.3760/cma.j.issn.0366-6999.2011.19.037</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0366-6999
ispartof Chinese medical journal, 2011-10, Vol.124 (19), p.3164-3169
issn 0366-6999
2542-5641
language eng
recordid cdi_wanfang_journals_zhcmj201119037
source HEAL-Link subscriptions: Lippincott Williams & Wilkins
subjects Humans
MicroRNAs - physiology
miRNA
Multiple Myeloma - genetics
基因表达
多发性骨髓瘤
恶性肿瘤
放松管制
监管机构
表观遗传
非编码RNA
title miRNA deregulation in multiple myeloma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A03%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=miRNA%20deregulation%20in%20multiple%20myeloma&rft.jtitle=Chinese%20medical%20journal&rft.au=Bi,%20Chong%20Lei&rft.date=2011-10&rft.volume=124&rft.issue=19&rft.spage=3164&rft.epage=3169&rft.pages=3164-3169&rft.issn=0366-6999&rft.eissn=2542-5641&rft_id=info:doi/10.3760/cma.j.issn.0366-6999.2011.19.037&rft_dat=%3Cwanfang_jour_proqu%3Ezhcmj201119037%3C/wanfang_jour_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c267t-7a1db8e30d37b9e97bf281748855cc3476043fe8042f0c153b9d2f06241b01463%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=901641676&rft_id=info:pmid/22040573&rft_cqvip_id=39797616&rft_wanfj_id=zhcmj201119037&rfr_iscdi=true